UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000051727 |
|---|---|
| Receipt number | R000059037 |
| Scientific Title | Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron |
| Date of disclosure of the study information | 2023/07/27 |
| Last modified on | 2024/12/20 22:12:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Elucidation of genes involved in individual differences in ondansetron sensitivity
Acronym
Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron
Scientific Title
Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron
Scientific Title:Acronym
Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron
Region
| Japan |
Condition
Condition
Patients undergoing orthognathic surgery
Classification by specialty
| Oral surgery |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
We will analyze the genes that cause PONV after administration of ondansetron-dexamethasone.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Postoperative nausea attitude,Frequency of vomiting (2 hours later, 24 hours later)
Key secondary outcomes
Whether to use rescue anti-emetics (metoclopramide)
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 50 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Eligible patients meet the criteria of the American Society of Anesthesiologists(ASA) physical status of I-II.
Key exclusion criteria
Eligible patients meet the criteria of the American Society of Anesthesiologists(ASA) physical status of 3-5.
Patients without consent.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Kyotaro |
| Middle name | |
| Last name | Koshika |
Organization
Tokyo Dental College
Division name
Dental Anesthesiology
Zip code
101-0061
Address
2-9-18 Misakicho,Chiyodaku,Tokyo-to 101-0061 Japan
TEL
03-6380-9001
koshikakyotarou@tdc.ac.jp
Public contact
Name of contact person
| 1st name | Yuna |
| Middle name | |
| Last name | Kang |
Organization
Tokyo Dental College
Division name
Dental Anesthesiology
Zip code
101-0061
Address
2-9-18 Misakicho,Chiyodaku,Tokyo-to 101-0061 Japan
TEL
03-6380-9001
Homepage URL
yunakang@tdc.ac.jp
Sponsor or person
Institute
Tokyo Dental College
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tokyo Dental College Ethics Review Board
Address
2-9-18 Misakicho,Chiyodaku,Tokyo-to 101-0061 Japan
Tel
03-6380-9001
drinri@tdc.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 07 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2023 | Year | 05 | Month | 02 | Day |
Date of IRB
| 2023 | Year | 05 | Month | 02 | Day |
Anticipated trial start date
| 2023 | Year | 05 | Month | 03 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Administer dexamethasone before surgery and ondansetron at the end of surgery.
Management information
Registered date
| 2023 | Year | 07 | Month | 27 | Day |
Last modified on
| 2024 | Year | 12 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059037
